Characteristics

Complete sample

(n=193)

Albumin<3.3 gr/dl

(n=58)

Albumin>3.3gr/dl

(n=135)

p

Age

32,1± 6.24

33.7±6.5

31.4±6

0.021

Nuliparous (n=18)

31.6%

25.9%

34.1%

0.261

Twin pregnancy (n=9)

4.6%

8.6%

3%

0.131

In vitro fecundation(n=14)

7.3%

18.6%

5.1%

0.007

Previous PE

25.0%

22.4%

26.1%

0.586

Previous E

3.1%

0.0%

4.3%

0.173

Previous DM

28.5%

34.5%

25.9%

0.227

Type 1 (n=5)

8.6%

13.6%

5.6%

0.178

Type 2 DM (n=13)

22.4%

31.8%

16.7%

Gestational DM (n=40)

69%

54.5%

77.8%

Caesareansection

48.4%

56.9%

44.8%

0.123

Chronic HTN

39%

50%

34.3%

0.041

Gestational HTN

61%

50%

65.7%

Weight gain (Kg) up to 32th week

10.54±6

12±5.8

10±6.145

0.95

APGAR test

8.63±1.2

8.49±1.1

8.69±1.3

0.04

Table 1. Characteristics and background of the population of the study

PE: Preeclampsia. E: Eclampsia. DM: diabetes mellitus. HTNA: hypertension

Characteristics

Complete sample(n=193)

Albumin<3.3 gr/dl

(n=58)

Albumin>3.3gr/dl

(n=135)

p

Hematocrit

(mg/dl)

36.1±2.9

36.3±3

35.9±2.8

0.021

Uricacid (mg/dl)

4.6±13

5.0±1.6

4.4±1.2

0.01

SBP (mmHg)

128±17

134±15.4

125.6±17

0.007

DBP (mmHg)

82.2±12

76.4±11.7

72.8±11.8

0.02

Albuminemia (g/dl)

3.48±0.3

3.15±0.2

3.6±0.2

0.000

Proteinuria 24h (g/l)

0.48±1.09

1.0±1.7

0.3±0.1

0.000

BP-loweringtreatment

56.6%

67.2%

54.9%

0.111

Acetylsalicilicacid

27.2%

41.4%

21.1%

0.04

PE*

29.5%

43.1%

23.7%

0.006

Childbirthweight(gr)

2982±697,7

2756±726

3076±666

0.004

Gestational age at delivery (weeks)

37.4±4

36.7±2.9

38±2.4

0.002

Table 2: Analytic parameters, blood pressure, pharmacological treatment and delivery variables

*Includes: PE, HELLP syndrome and Eclampsia. BP: Blood pressure; SBP: Systolic blood pressure; DBP: Diastolic Blood pressure